Breaking News Instant updates and real-time market news.

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

12:16
09/23/18
09/23
12:16
09/23/18
12:16

Nightstar reports proof of concept data from dose escalation in XIRIUS trial

Nightstar Therapeutics announced that positive preliminary safety and efficacy data of NSR-RPGR from the dose escalation study in the Phase 1/2 XIRIUS trial were presented at the EURETINA 2018 Congress. XIRIUS is a Phase 1/2, open-label, dose-ranging, single-eye clinical trial consisting of a dose escalation study and an expansion study with sites in both the U.S. and the U.K. The XIRIUS trial is intended to evaluate the safety, tolerability and efficacy of NSR-RPGR for the treatment of XLRP in patients with the RPGR mutation. Available safety data from the 15 treated patients in cohorts 1-5 indicates that NSR-RPGR was well-tolerated. The safety profile in the dose escalation study is generally consistent with that of surgical vitrectomy procedures and what has been observed in clinical trials of other ocular gene therapies. No serious adverse events related to treatment were reported and no early discontinuations or dose limiting toxicity were observed. Mild drug-related inflammation that potentially dampened efficacy was seen in the treated eyes of cohorts 4-5, with treatment efficacy observed to have been rescued in patients who received additional steroid treatment. Adverse events of varying severity and duration related to the vitrectomy procedure or drug have been observed in the dose escalation study such as retinal changes, intraocular inflammation and visual disturbances. The Data Monitoring Committee reviewed preliminary safety data for cohorts 1-5 and recommended escalation to cohort 6. The DMC also has not restricted pediatric enrollment in either the dose escalation study or expansion study. Based on the totality of results to date, Nightstar expects to initiate enrollment of the expansion study in the XIRIUS trial in the fourth quarter of 2018. The expansion study is intended to enroll approximately 30 adult and pediatric patients at a therapeutic dose informed by the dose escalation study and a low-dose control group of approximately 15 patients. Preliminary efficacy data from the expansion study is expected to be available in mid-2019, with one-year follow-up data expected to be available in 2020.

  • 24

    Sep

NITE Nightstar Therapeutics
$25.64

-1.71 (-6.25%)

06/27/18
OPCO
06/27/18
DOWNGRADE
OPCO
Perform
Nightstar Therapeutics downgraded to Perform from Outperform at Oppenheimer
08/22/18
JANY
08/22/18
INITIATION
JANY
Buy
Nightstar Therapeutics initiated with a Buy at Janney Montgomery Scott
Janney Montgomery Scott analyst Yun Zhong initiated Nightstar Therapeutics with a Buy.
08/22/18
08/22/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BJ's Restaurants (BJRI) initiated with a Buy at Maxim. 2. Nightstar Therapeutics (NITE) initiated with a Buy at Janney Montgomery Scott. 3. Endava (DAVA) initiated with a Hold at Deutsche Bank. 4. Cardiovascular Systems (CSII) initiated with a Buy at Stifel. 5. Wright Medical (WMGI) initiated with a Buy at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/18
MZHO
09/04/18
NO CHANGE
Target $24
MZHO
Buy
Nightstar Therapeutics price target raised to $24 from $20 at Mizuho
Mizuho analyst Difei Yang raised her price target for Nightstar Therapeutics to $24 saying she'd be a buyer of the stock ahead of the preliminary data from the company's X-linked retinitis pigmentosa program on September 22 at the European Society of Retina Specialists 2018 Meeting in Vienna, Austria. The data will be an "important catalyst" as positive results would further validate the Nightstar platform and be a "significant de-risking event," Yang tells investors in a research note. She keeps a Buy rating on Nightstar Therapeutics.

TODAY'S FREE FLY STORIES

03:40
10/15/18
10/15
03:40
10/15/18
03:40
General news
FX Action: USD-CAD has settled in the lower 1.3000s »

FX Action: USD-CAD has…

03:15
10/15/18
10/15
03:15
10/15/18
03:15
General news
FX Update: The Yen has traded moderately firmer »

FX Update: The Yen has…

BAC

Bank of America

$28.42

0.07 (0.25%)

20:25
10/14/18
10/14
20:25
10/14/18
20:25
Earnings
Notable company reporting before Monday's open »

The notable company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 24

    Oct

JPM

JPMorgan

$106.88

-1.18 (-1.09%)

19:56
10/14/18
10/14
19:56
10/14/18
19:56
Periodicals
JPMorgan's Dimon cancels plans to attend Saudi investor event, Reuters says »

JP Morgan CEO Jamie Dimon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 26

    Feb

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

19:15
10/14/18
10/14
19:15
10/14/18
19:15
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

ATVI

Activision Blizzard

$77.99

4.13 (5.59%)

SNE

Sony

$55.50

-0.01 (-0.02%)

MSFT

Microsoft

$109.54

3.63 (3.43%)

TSLA

Tesla

$259.11

6.93 (2.75%)

JPM

JPMorgan

$106.88

-1.18 (-1.09%)

WFC

Wells Fargo

$52.12

0.7 (1.36%)

BAC

Bank of America

$28.42

0.07 (0.25%)

SCHW

Charles Schwab

$49.02

0.89 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 19

    Oct

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 13

    Nov

  • 28

    Nov

  • 13

    Dec

  • 26

    Feb

  • 03

    Mar

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

AAPL

Apple

$222.10

7.61 (3.55%)

19:11
10/14/18
10/14
19:11
10/14/18
19:11
Periodicals
Apple buys music analytics startup Asaii, Axios reports »

Apple has acquired Asaii,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.65

-0.16 (-1.82%)

18:15
10/14/18
10/14
18:15
10/14/18
18:15
Periodicals
Ford chairman cancels visit to Saudi investor conference, Reuters reports »

Ford Motor Chairman Bill…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HON

Honeywell

$156.15

2.45 (1.59%)

17:16
10/14/18
10/14
17:16
10/14/18
17:16
Hot Stocks
Honeywell business jet aviation forecast projects 7,700 new aircraft deliveries »

The business jet industry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

T

AT&T

$32.23

0.48 (1.51%)

, CMCSA

Comcast

$34.61

0.93 (2.76%)

16:41
10/14/18
10/14
16:41
10/14/18
16:41
Hot Stocks
Box Office Battle: 'Venom' wins domestic box office again with $35.7M »

Sony's (SNE)…

T

AT&T

$32.23

0.48 (1.51%)

CMCSA

Comcast

$34.61

0.93 (2.76%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$55.50

-0.01 (-0.02%)

FOX

21st Century Fox

$44.94

0.15 (0.33%)

FOXA

21st Century Fox

$45.36

0.23 (0.51%)

LGF.A

Lionsgate

$22.51

0.79 (3.64%)

DIS

Disney

$112.61

1.44 (1.30%)

VIAB

Viacom

$31.39

0.2 (0.64%)

VIA

Viacom

$34.46

-0.25 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

16:33
10/14/18
10/14
16:33
10/14/18
16:33
Conference/Events
L3 Technologies and Harris to hold a joint conference call »

The companies hold a…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

ROK

Rockwell Automation

$172.89

2.3 (1.35%)

16:19
10/14/18
10/14
16:19
10/14/18
16:19
Hot Stocks
Harpak-ULMA, Rockwell Automation to deliver smart, connected packaging machines »

Harpak-ULMA announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$77.99

4.13 (5.59%)

, SNE

Sony

$55.50

-0.01 (-0.02%)

16:16
10/14/18
10/14
16:16
10/14/18
16:16
Hot Stocks
New Call of Duty delivers biggest launch day one digital sales for Activision »

Call of Duty: Black Ops 4…

ATVI

Activision Blizzard

$77.99

4.13 (5.59%)

SNE

Sony

$55.50

-0.01 (-0.02%)

MSFT

Microsoft

$109.54

3.63 (3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

COL

Rockwell Collins

$134.20

-0.26 (-0.19%)

, ERJ

Embraer

$19.24

-0.095 (-0.49%)

16:11
10/14/18
10/14
16:11
10/14/18
16:11
Hot Stocks
Rockwell Collins' Pro Line Fusion selected for Embraer's Praetor 500/600 jets »

Rockwell Collins'…

COL

Rockwell Collins

$134.20

-0.26 (-0.19%)

ERJ

Embraer

$19.24

-0.095 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HON

Honeywell

$156.15

2.45 (1.59%)

, ERJ

Embraer

$19.24

-0.095 (-0.49%)

16:06
10/14/18
10/14
16:06
10/14/18
16:06
Hot Stocks
Honeywell engines to power Embraer's latest executive aircraft models »

Honeywell (HON) engines…

HON

Honeywell

$156.15

2.45 (1.59%)

ERJ

Embraer

$19.24

-0.095 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

GWRE

Guidewire

$88.77

1.63 (1.87%)

16:00
10/14/18
10/14
16:00
10/14/18
16:00
Hot Stocks
Guidewire announces 2018.2 release of P&C insurance industry platform »

Guidewire announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSC

Acquired by JPM

$0.00

(0.00%)

, GS

Goldman Sachs

$213.91

0.93 (0.44%)

13:14
10/14/18
10/14
13:14
10/14/18
13:14
Periodicals
Barclays to take on Goldman with new U.S. retail current account, FT reports »

Barclays (BCS) is…

BSC

Acquired by JPM

$0.00

(0.00%)

GS

Goldman Sachs

$213.91

0.93 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

LLL

L3 Technologies

$195.99

0.74 (0.38%)

12:48
10/14/18
10/14
12:48
10/14/18
12:48
Earnings
L3 Technologies raises FY18 adjusted EPS view to $10.20-$10.30 from $9.80-$10.00 »

FY18 consensus $10.05.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

LLL

L3 Technologies

$195.99

0.74 (0.38%)

12:42
10/14/18
10/14
12:42
10/14/18
12:42
Earnings
L3 Technologies reports preliminary Q3 adjusted EPS $2.85, consensus $2.41 »

Reports preliminary Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

12:28
10/14/18
10/14
12:28
10/14/18
12:28
Earnings
Harris raises FY19 cont ops EPS $7.80-$7.90, consensus $7.84 »

Sees FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

12:24
10/14/18
10/14
12:24
10/14/18
12:24
Earnings
Harris reports Q1 adjusted EPS $1.78, consensus $1.71 »

Reports Q1 revenue $1.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

12:18
10/14/18
10/14
12:18
10/14/18
12:18
Hot Stocks
Harris, L3 Technologies to combine in merger of equals »

Harris Corporation (HRS)…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

LOACU

Longevity Acquisition Corporation

$10.24

(0.00%)

12:11
10/14/18
10/14
12:11
10/14/18
12:11
Hot Stocks
Longevity Acquisition announces separate trading of ordinary shares, rights »

Longevity Acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

08:10
10/14/18
10/14
08:10
10/14/18
08:10
Periodicals
Harris, L3 Technologies near agreement to merge, WSJ reports »

Harris Corporation (HRS)…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

SCHW

Charles Schwab

$49.02

0.89 (1.85%)

19:36
10/13/18
10/13
19:36
10/13/18
19:36
Conference/Events
Charles Schwab to host conference call »

Fall business update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 19

    Oct

FDX

FedEx

$220.97

3.54 (1.63%)

16:46
10/13/18
10/13
16:46
10/13/18
16:46
Conference/Events
FedEx management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.